Phagocytosis and burst activity of granulocytes and monocytes after stem cell transplantation

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 6, 1997, Pages 634-637

  Miyagawa, Blythe ^a   Klingemann, Hans G ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031171183     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2143(97)90198-0     Document Type: Article

References (12)

1. Atkinson K, Storb R, Prentice RL, et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720-6.
2. Clark RA, Johnson FL, Klebanoff SJ, Thomas ED. Defective neutrophil chemotaxis in bone marrow transplant recipients. J Clin Invest 1976;58:22-31.
3. Sosa R, Weiden PL, Storb R, Syrotuck ED, Thomas ED. Granulocyte function in human allogeneic marrow graft recipients. Exp Hematol 1980;8:1183-9.
4. Bernaudin F, Cordonnier C, Escudier E, Vernant JP, Bernaudin JF. Polymorphnuclear chemotaxis after allogeneic bone marrow tranplantation. Exp Hematol 1985;13(suppl 17):95.
5. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80.
6. Brochu S, Perreault C, Belanger R. Evaluation of Fc-dependent monocyte-macrophage function in bone marrow transplant recipients. Exp Hematol 1989;17:948-51.
7. Kohn FR, Phillips GL, Klingemann H-G. Regulation of tumor necrosis factor-α production and gene expression in monocytes. Bone Marrow Transplant 1992;9:369-76.
8. Pechumer H, Leinisch E, Bender-Goetze C, Ziegler-Heitbrock HWL. Recovery of monocytes after bone marrow transplantation: rapid reappearance of tumor necrosis factor alpha and interleukin-6 production. Transplantation 1991;52: 674-98.
9. Winston DJ, Territo MC, Ho WS, Miller MJ, Gale RP, Golde DW. Alveolar macrophage dysfunction in human bone marrow transplant recipients. Am J Med 1982;73:859-66.
10. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991;77:673-7.
11. Ohsaka A, Kitagawa S, Sakamoto S, et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989;74: 2743-8.
12. Yuo A, Kitagawa S, Ohsaka A, et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimuation of C3bi receptor expression and adherence. Blood 1989;74:2144-9.